Furthermore, activated CD8Teff cells enhance their tumor-killing capacity by secreting increased levels of CXCL13, which mediates interactions with NK cells, tumor cells, CAFs, and vascular endothelial cells. The gene discussed is CXCL13; the disease is neoplasm.